1. Precision medicine in cancer treatment: Revolutionizing care through proteomics, genomics, and personalized therapies
- Author
-
Jawdekar, Riddhi, Mishra, Vaishnavi, Hatgoankar, Kajal, Tiwade, Yugeshwari R., and Bankar, Nandkishor J.
- Subjects
Research ,Patient outcomes ,Methods ,Precision medicine -- Patient outcomes ,CAR T-cell therapy -- Methods -- Patient outcomes ,DNA sequencing -- Methods ,Genomics -- Research ,Proteomics -- Research ,Nucleotide sequencing -- Methods - Abstract
Author(s): Riddhi Jawdekar [1]; Vaishnavi Mishra [2]; Kajal Hatgoankar (corresponding author) [1]; Yugeshwari R. Tiwade [3]; Nandkishor J. Bankar [2] INTRODUCTION The cause of cancer has been the subject of [...], Recent developments in biotechnology have allowed us to identify unique and complicated biological traits associated with cancer. Genomic profiling through next-generation sequencing (NGS) has revolutionized cancer therapy by evaluating hundreds of genes and biomarkers in a single assay. Proteomics offers blood-based biomarkers for cancer detection, categorization, and therapy monitoring. Immune oncology and chimeric antigen receptor (CAR-T cell) therapy use the immune system to combat cancer. Personalized cancer treatment is on the rise. Although precision medicine holds great promise, its widespread application faces obstacles such as lack of agreement on nomenclature, the difficulty of classifying patients into distinct groups, the difficulties of multimorbidity, magnitude, and the need for prompt intervention. This review studies advances in the era of precision medicine for cancer treatment; the application of genomic profiling techniques, NGS, proteomics, and targeted therapy; and the challenge in the application of precision medicine and the beneficial future it holds in cancer treatment. Keywords: Genomics, next-generation sequencing, precision medicine, proteomics, targeted therapy
- Published
- 2024
- Full Text
- View/download PDF